1 Min Read
Feb 28 (Reuters) - Booz Allen Hamilton Holding Corp:
* FDA SELECTS BOOZ ALLEN FOR SPOT ON $300M AWARD TO OPTIMIZE DRUG REVIEW MANAGEMENT BY ENHANCING INFORMATICS PLATFORM Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.